MRI scan study of brain tumors using special carbon imaging
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed brain tumor on imaging (such as glioma, meningioma, or brain metastasis) and have not started chemo or radiation yet
- You are between 18 and 70 years old
- You can read and speak English well enough to understand the study and sign consent (Spanish may be allowed once the study is set up)
- You can safely have an MRI with contrast (if needed) and can complete the scan sessions
- If you can become pregnant, you must use reliable birth control and you must not be pregnant or breastfeeding during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses two special types of MRI scans to better understand how far a high-grade brain tumor (aggressive brain cancer) has spread into surrounding brain tissue. The goal is to help doctors plan surgery or biopsy more precisely.
This study looks at how brain tumors use energy (“metabolism”) during planned surgical removal. It may help researchers learn what makes tumors grow and how to improve future brain tumor treatments.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This early study (Phase 1) tests a new kind of MRI that uses a special labeled sugar (pyruvate) to help learn how infiltrating gliomas behave in the brain. If you have a suspected or known infiltrating glioma and are having brain surgery or biopsy, this may help your doctors learn more about tumor metabolism and guide future care.
This early-phase study tests a special MRI scan using C-13 pyruvate to help identify and understand gliomas (a type of brain tumor) in people with brain tumors going to surgery or biopsy. It may help doctors see tumor signals better before or around the time of your procedure.
Hear when a new Brain Tumor Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.